The Net Benefit (Δ) is a measure of the benefit‐risk balance in clinical trials, based on generalized pairwise comparisons (GPC) using several prioritized outcomes and thresholds of clinical relevance. We… Click to show full abstract
The Net Benefit (Δ) is a measure of the benefit‐risk balance in clinical trials, based on generalized pairwise comparisons (GPC) using several prioritized outcomes and thresholds of clinical relevance. We extended Δ to N‐of‐1 trials, with a focus on patient‐level and population‐level Δ.
               
Click one of the above tabs to view related content.